Arbutus Biopharma Corp (NASDAQ:ABUS)
| 2.74 BATS BZX Real-Time Price As of 10:59am ET |  +0.03 / +1.11%Today’s Change | 2.41 Today|||52-Week Range 6.50 | -29.56% Year-to-Date |
Latest ABUS News | Press Releases
No recent news for Arbutus Biopharma Corp.
Today’s Trading
| Previous close | 2.71 |
| Today’s open | 2.61 |
| Day’s range | 2.72 - 2.77 |
| Volume | 33,273 |
| Average volume (3 months) | 7,719,138 |
| Market cap | $363.2M |
Data as of 10:59am ET, 01/26/2022
Growth & Valuation
| Earnings growth (last year) | +65.36% |
| Earnings growth (this year) | +13.60% |
| Earnings growth (next 5 years) | +3.00% |
| Revenue growth (last year) | +15.02% |
| P/E ratio | NM |
| Price/Sales | 38.94 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BDSIBioDelivery Sciences... | -0.04 | -0.94% |
| VRDNViridian Therapeutic... | +0.34 | +2.00% |
| PRQRProQR Therapeutics N... | +0.20 | +3.94% |
| MRNSMarinus Pharmaceutic... | +0.01 | +0.10% |
Data as of 11:00am ET, 01/26/2022
Financials
| Next reporting date | March 10, 2022 |
| EPS forecast (this quarter) | -$0.19 |
| Annual revenue (last year) | $6.9M |
| Annual profit (last year) | -$63.7M |
| Net profit margin | -921.97% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Warminster, Pennsylvania |
Forecasts
